Hyperlipidemia in Patients with Calcific Tendinitis

Esra  Polat; Fatih Özyer; Elif İlkay Yüce; İbrahim Halil İnanç

doi:10.5152/EurJTher.2022.22040

Authors

Esra Polat Department of Cardiology, Fethiye State Hospital, Muğla, Turkey https://orcid.org/0000-0002-2330-2816
Fatih Özyer Department of Orthopedics and Traumatology, Fethiye State Hospital, Muğla, Turkey https://orcid.org/0000-0003-0996-7456
Elif İlkay Yüce Department of Cardiology, Fethiye State Hospital, Muğla, Turkey https://orcid.org/0000-0001-9078-0941
İbrahim Halil İnanç Department of Cardiology, Kırıkkale Yüksek İhtisas Hospital, Kırıkkale, Turkey https://orcid.org/0000-0003-4046-6748

DOI:

https://doi.org/10.5152/EurJTher.2022.22040

Keywords:

Calcific tendinitis, hyperlipidemia, hypertriglyceridemia, LDL, shoulder

Abstract

Objective: Calcific tendinitis is a disease of unclear etiology and is associated with metabolic diseases. Hyperlipidemia, one of the metabolic diseases with systemic effects, may be associated with tendinopathy and tendinitis. In this study, we aimed to evaluate the relationship between hyperlipidemia and hypertriglyceridemia, calcific tendinitis, the location of tendinitis, and the frequency of severely symptomatic tendinitis attacks.

Methods: This retrospective study included a total of 2055 patients diagnosed with calcific tendinitis between August 1, 2019, and August 1, 2021. The patients were evaluated in terms of their hyperlipidemia and hypertriglyceridemia status, statin and/or fibrate use, and the frequency of tendinitis, and the location of attack.

Results: It was observed that 64.4% (n=230) of the patients had hyperlipidemia and 11.8% (n=42) had hypertriglyceridemia. It was determined that the most common tendinitis area among 357 patients was the shoulder. There was no statistically significant difference between the frequency of attacks (P = .712), and the location of attack (P = .069) in patients with hyperlipidemia. There was no statistically significant difference between the frequency of attacks (P =.735) and the location of attack (P =.286) in patients with hypertriglyceridemia. However, a statistically significant difference was found between the attack area (P =.032) in patients with triglyceride values higher than the target recommended values.

Conclusion: The frequency of hyperlipidemia is high in patients with calcific tendinitis; it will be useful to evaluate patients with calcific tendinitis in terms of hyperlipidemia.

Metrics

Metrics Loading ...

References

Hayes CW, Conway WF. Calcium hydroxyapatite deposition disease. RadioGraphics. 1990;10(6):1031-1048.

Kim MS, Kim IW, Lee S, Shin SJ. Diagnosis and treatment of calcific tendinitis of the shoulder. Clin Shoulder Elb. 2020;23(4):210-216.

Hurt G, Baker CL. Calcific tendinitis of the shoulder. Orthop Clin North Am. Orthopedic Clinics. 2003;34(4):567-575.

Siegal DS, Wu JS, Newman JS, Del Cura JL, Hochman MG. Calcific tendinitis: a pictorial review. Can Assoc Radiol J. 2009;60(5):263-272.

García VP, Moya CP, Martín AM. Tendinitis calcificante prevertebral aguda: a propósito de un caso y revisión de la literatura. Rev Española Cir Ortop Traumatol. 2012;56(5):389-392.

Huang K, Murphy D, Dehghan N. Calcific tendinitis of the gluteus maximus of a 53-year-old woman. CMAJ. 2017;189(50):E1561.

Su YC, Chung CH, Ke MJ, Chen LC, Chien WC, Wu YT. Increased risk of shoulder calcific tendinopathy in diabetes mellitus: a nationwide, population‐based, matched cohort study. Int J Clin Pract. 2021;75(10):e14549.

Oliva F, Piccirilli E, Berardi AC, Tarantino U, Maffulli N. Influence of thyroid hormones on tendon homeostasis. Adv Exp Med Biol. 2016;920:133-138.

Yang Y, Lu H, Qu J. Tendon pathology in hyper chole stero laemi a patients: epidemiology, pathogenesis and management. J Orthop Translat. 2019;16:14-22.

Abboud JA, Kim JS. The effect of hypercholesterolemia on rotator cuff disease. Clin Orthop Relat Res. 2010;468(6):1493-1497.

Vermeer BJ, Mateysen AA, van Gent CM, van Sabben RM, Emeis JJ. The lipid composition and localization of free and esterified cholesterol in different types of xanthomas. J Invest Dermatol. 1982;78(4):305-308.

Oosterveer DM, Versmissen J, Yazdanpanah M, et al. 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia. Atherosclerosis. 2009;206(1):223-227.

Oberkersch R, Maccari F, Bravo AI, Volpi N, Gazzaniga S, Calabrese GC. Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hyper chole stero laemi a in a rat model. Int J Exp Pathol. 2014;95(3):181-190.

Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188.

Lin CC, Nfor ON, Su CL, Hsu SY, Tantoh DM, Liaw YP. Interactive associations of sex and hyperlipidemia with calcific tendinitis of the shoulder in Taiwanese adults. Medicine. 2020;99(46):e23299.

Harvie P, Pollard TC, Carr AJ. Calcific tendinitis: natural history and association with endocrine disorders. J Shoulder Elbow Surg. 2007;16(2):169-173.

Longo UG, Mazzola A, Carotti S, et al. The role of estrogen and progesterone receptors in the rotator cuff disease: a retrospective cohort stud y. BMC Musculoskelet Disord. 2021;22(1):1.

Motta Gda R, Amaral MV, Rezende E, et al. Evidence of genetic variations associated with rotator cuff disease. J Shoulder Elbow Surg. 2014;23(2):227-235.

Longo UG, Franceschi F, Spiezia F, Forriol F, Maffulli N, Denaro V. Triglycerides and total serum cholesterol in rotator cuff tears: do they matter? Br J Sports Med. 2010;44(13):948-951.

Lin TTL, Lin CH, Chang CL, Chi CH, Chang ST, Sheu WHH. The effect of diabetes, hyperlipidemia, and statins on the development of rotator cuff disease: a nationwide, 11-year, longitudinal, populationbased follow-up study. Am J Sports Med. 2015;43(9):2126-2132.

Teichtahl AJ, Brady SR, Urquhart DM, et al. Statins and tendinopathy: a systematic review. Med J Aust. 2016;204(3):115-21.e1. [